BioSpace News Archive

Feb. 10, 2020 14:54 UTC Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY ™ (Pemetrexed for Injection) -- Eagle has exclusive rights to commercialize product for four months beginning February 1, 2022 -- WOODCLIFF LAKE, N.J.--( BUSINESS WIRE )-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has received final approval from the U.S. Food and Drug Administration (“FDA”) for its novel product, PEMFEXY™ (pemetrexed for

Ground-Breaking Medical Devices That Rethink The Way Women’s Healthcare is Delivered Are Recognized in Design Industry

Embark announces preliminary research findings linking elevated levels of inbreeding to shorter lifespan in dogs; partners with breeders in commitment to improve long-term canine health

Feb. 10, 2020 15:00 UTC Bioventus Updates US Label for EXOGEN ® Ultrasound Bone Healing System DURHAM, N.C.--( BUSINESS WIRE )-- Bioventus , a global leader in orthobiologic solutions, has updated the indications for use for its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and promote fracture healing. It has an 86% heal rate for fractures not healing on their own 1 and p

Feb. 10, 2020 15:00 UTC The Digital MedTech Conference to showcase the growing and evolving digital medtech landscape WASHINGTON & SAN DIEGO--( BUSINESS WIRE )-- The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s D

Bold Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has received clearance from Health Canada to initiate a Phase 1b trial of its first-in-class anti-resistance therapeutic, BOLD-100, in combination with FOLFOX for the treatment of gastric, pan

Feb. 10, 2020 15:00 UTC --Company is Recognized Top 1% among 4,000 applicants from 133 Countries-- GAITHERSBURG, Md.--( BUSINESS WIRE )-- Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced that the company has been selected to participate in the Accelerate Program at the Startup Grind Global 2020 Conference,

MiraMed Global Services, Inc. (MiraMed), a leader in healthcare business process outsourcing (BPO) solutions, is pleased to announce the successful completion of its SOC (System and Organization Controls) examination for its family of companies.

Foot Levelers, the world’s leader in custom-made orthotics, has introduced the latest version of its innovative Kiosk, launching the new technology at Parker Seminars Vegas.

Comar, a specialty packaging, device, and component supplier serving the Medical, Pharmaceutical, Consumer Healthcare, Personal and Home Care, Food and Beverage, and other niche market segments is building a custom facility in Rancho Cucamonga, CA.